PROGYNY, INC. (PGNY): Price and Financial Metrics
PGNY Price/Volume Stats
| Current price | $31.88 | 52-week high | $44.95 |
| Prev. close | $32.75 | 52-week low | $29.44 |
| Day low | $31.80 | Volume | 1,295,908 |
| Day high | $33.50 | Avg. volume | 786,044 |
| 50-day MA | $36.86 | Dividend yield | N/A |
| 200-day MA | $36.24 | Market Cap | 3.06B |
PGNY Stock Price Chart Interactive Chart >
PROGYNY, INC. (PGNY) Company Bio
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
Latest PGNY News From Around the Web
Below are the latest news stories about PROGYNY INC that investors may wish to consider to help them evaluate PGNY as an investment opportunity.
Executive Chairman David Schlanger Sells 162,906 Shares of Progyny Inc (PGNY)On December 22, 2023, Executive Chairman David Schlanger sold 162,906 shares of Progyny Inc (NASDAQ:PGNY), as reported in a recent SEC Filing. |
24 Countries With Biggest Population DeclineThis article will list countries where population is continuously decreasing and highlight the major reasons behind this population decline. You can skip our detailed overview of the world’s population patterns and read 10 Countries With Biggest Population Decline. Recent estimates from the United Nations predict that the global population will reach approximately 8.5 billion by 2030, expand […] |
4 Unstoppable Multibaggers to Buy in 2024 and Hold for the Next DecadeEven after posting solid results so far in 2023, these four stocks still offer long-term multibagger potential. |
Returns On Capital Are Showing Encouraging Signs At Progyny (NASDAQ:PGNY)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an... |
Does Progyny (PGNY) have a Long Runway for Growth?Polen Capital, an investment management company, released its “Polen Global SMID Company Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund returned -6.59% gross and -6.64% net of fees compared to -3.55% return for the MSCI ACWI SMID Capitalization Index. Negative security selection drove the underperformance of the […] |
PGNY Price Returns
| 1-mo | -12.15% |
| 3-mo | -14.78% |
| 6-mo | 0.66% |
| 1-year | -6.40% |
| 3-year | -35.40% |
| 5-year | N/A |
| YTD | -14.25% |
| 2023 | 19.36% |
| 2022 | -38.13% |
| 2021 | 18.78% |
| 2020 | 54.43% |
| 2019 | N/A |
Loading social stream, please wait...